NCT00625846 2020-02-26
Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
5 trialsNCT02393820 2019-10-29
PACSA-ORL02
UNICANCER
Phase 2 Completed
NCT01813136 2019-08-16
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Centre Leon Berard
Phase 2 Completed
NCT00454142 2015-12-17
Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01377298 2011-06-21
Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital
Phase 2 Unknown